Budget impact analysis is increasingly used as a tool to inform financial consequences of new health interventions. This session features budget impact analysis of interventions for the management of chronic obstructive pulmonary disease, Hemophilia B, and COVID-19 vaccine, as well as methodological considerations for incorporating time-to-event outcomes in budget impact analysis.

Seating is limited.